CHECKPOINT THERAPEUTICS
DEAD

Serial Number

86498366

Owner

Checkpoint Therapeutics, Inc.

Attorney

Devon E. White

Filing Date

Jan 8, 2015

Add to watchlist:

No watchlists yet
View on USPTO

CHECKPOINT THERAPEUTICS Trademark

Serial Number: 86498366

CHECKPOINT THERAPEUTICS is a trademark filed by Checkpoint Therapeutics, Inc. on January 8, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Checkpoint Therapeutics, Inc. (13 trademarks)

2 Gansevoort Street
New York, NY 10014

Entity Type: 03

Trademark Details

Filing Date

January 8, 2015

Registration Date

Not Registered

Published for Opposition

June 16, 2015

Goods & Services

Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the treatment of cancer, autoimmune diseases and disorder, rare diseases, genetic diseases, infectious diseases, central nervous system infections, gastrointestinal infections, genitourinary infections, ocular infections, dermatological infections, immune system infections, liver infections, hepatic infections, neurological disorders, tuberculosis, lung diseases, asthma, hypertension, cardiovascular diseases, immunologic diseases, immunologic deficiency syndromes, tumors, proliferative diseases, inflammatory diseases, inflammatory bowel diseases, inflammatory connective tissue diseases, psoriasis, ophthalmologic diseases, fibrotic diseases, metabolic diseases, dental and oral diseases, neurological diseases, Alzheimer´s disease, Huntington´s disease, Parkinson, cerebral palsy, brain injury, spinal cord injury, seizure disorders, congenital disorders, metabolic disorders, viral and infectious diseases and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief; Pharmaceutical products for the treatment and normalization of disorders of the body's circulatory system; Pharmaceutical products for the treatment of diseases of the blood or of the lymphatic circulatory system; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Sep 17, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 17, 2018 ABN6
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 24, 2018 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 24, 2018 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 6, 2018 EXRA
SOU EXTENSION 5 GRANTED
Feb 5, 2018 EX5G
SOU EXTENSION 5 FILED
Feb 2, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 2, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 12, 2017 EXRA
SOU EXTENSION 4 GRANTED
Aug 10, 2017 EX4G
SOU EXTENSION 4 FILED
Aug 10, 2017 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 10, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 14, 2017 EXRA
SOU EXTENSION 3 GRANTED
Jan 12, 2017 EX3G
SOU EXTENSION 3 FILED
Jan 12, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 12, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2016 EXRA
SOU EXTENSION 2 GRANTED
Aug 18, 2016 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 18, 2016 AITU
SOU EXTENSION 2 FILED
Jul 21, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 21, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 14, 2016 EXRA
SOU EXTENSION 1 GRANTED
Jan 12, 2016 EX1G
SOU EXTENSION 1 FILED
Jan 12, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 12, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 11, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 8, 2015 PREV
ASSIGNED TO LIE
May 6, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 14, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 14, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 14, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 14, 2015 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 14, 2015 GNRN
NON-FINAL ACTION E-MAILED
Apr 14, 2015 GNRT
NON-FINAL ACTION WRITTEN
Apr 14, 2015 CNRT
ASSIGNED TO EXAMINER
Apr 14, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 20, 2015 NWOS
NEW APPLICATION ENTERED
Jan 12, 2015 NWAP